Cuál es el precio por OptiNose, Inc. (OPTN)

Precio por OptiNose, Inc. (OPTN) es de$9.60

Cuál es la capitalización de mercado por OptiNose, Inc. (OPTN)

Capitalización de mercado por OptiNose, Inc. (OPTN) es $1.08B

OptiNose, Inc. (OPTN) Desdoblamientos de Acciones

OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.

Año	Desdoblamiento	Multiplicador	Multiplicador acumulado
2024-12-31	1:15	x0.066666666666667	x0.066666666666667

Año

Desdoblamiento

Multiplicador

Multiplicador acumulado

2024-12-31

1:15

x0.066666666666667

Empresa	Número de desdoblamientos de acciones	Multiplicador acumulado	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

Empresa

Número de desdoblamientos de acciones

Multiplicador acumulado

País